# Pan‐Chyr Yang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pan-chyr-yang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 60,433 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 119 |
| i10-index | 663 |
| OpenAlex ID | https://openalex.org/A5006814522 |
| ORCID iD | https://orcid.org/0000-0001-6330-6048 |
| Works | 1,316 |

## Researcher papers

Showing 12 of 20.

- [International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma](https://scholariq.org/papers/international-association-for-the-study-of-lung-cancer-american-thoracic-society/)
- [<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib](https://scholariq.org/papers/i-met-i-amplification-occurs-with-or-without-i-t790m-i-mutations-in-i-egfr-i/)
- [MicroRNA Signature Predicts Survival and Relapse in Lung Cancer](https://scholariq.org/papers/microrna-signature-predicts-survival-and-relapse-in-lung-cancer/)
- [Value of sonography in determining the nature of pleural effusion: analysis of 320 cases.](https://scholariq.org/papers/value-of-sonography-in-determining-the-nature-of-pleural-effusion-analysis-of/)
- [Pretreatment Epidermal Growth Factor Receptor ( <i>EGFR</i> ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer](https://scholariq.org/papers/pretreatment-epidermal-growth-factor-receptor-i-egfr-i-t790m-mutation-predicts/)
- [p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug](https://scholariq.org/papers/p53-controls-cancer-cell-invasion-by-inducing-the-mdm2-mediated-degradation-of/)
- [Effectiveness of Tyrosine Kinase Inhibitors on “Uncommon” Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non–Small Cell Lung Cancer](https://scholariq.org/papers/effectiveness-of-tyrosine-kinase-inhibitors-on-uncommon-epidermal-growth-factor/)
- [Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling](https://scholariq.org/papers/cancer-associated-fibroblasts-regulate-the-plasticity-of-lung-cancer-stemness/)
- [Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial](https://scholariq.org/papers/afatinib-for-patients-with-lung-adenocarcinoma-and-epidermal-growth-factor/)
- [Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression](https://scholariq.org/papers/proteogenomics-of-non-smoking-lung-cancer-in-east-asia-delineates-molecular/)
- [Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression](https://scholariq.org/papers/opposite-effects-of-m1-and-m2-macrophage-subtypes-on-lung-cancer-progression/)
- [Tumor-Associated Macrophage-Induced Invasion and Angiogenesis of Human Basal Cell Carcinoma Cells by Cyclooxygenase-2 Induction](https://scholariq.org/papers/tumor-associated-macrophage-induced-invasion-and-angiogenesis-of-human-basal/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Pleural and Pulmonary Diseases](https://scholariq.org/topics/pleural-and-pulmonary-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.